CRP and Cowden disease: There were no significant differences in age, sex, disease course, involved lesions, CD behaviors, surgical or medication history, CRP, ESR, BMI, IBDQ, and SES-CD scores in the thalidomide group and the placebo group (all P > 0.05, Table 1).